Page last updated: 2024-11-12

lodoxamide tromethamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lodoxamide tromethamine: an orphan drug; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11192129
CHEMBL ID3989725
MeSH IDM0077622

Synonyms (39)

Synonym
63610-09-3
lodoxamide tromethamine (usan)
alomide (tn)
D04762
acetic acid, 2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxo-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
alomide
lodoxamide tromethamine
u 42,585e
lodoxamide tromethamine [usan]
u 42585e
u-42,585e
n,n'-(2-chloro-5-cyano-m-phenylene)dioxamic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
u-42585e
AKOS016009147
unii-50lv9a548l
50lv9a548l ,
lodoxamide trometamol
lodoxamide tromethamine [who-dd]
acetic acid, 2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis 2-oxo-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
lodoxamide tromethamine [vandf]
lodoxamide tromethamine [orange book]
lodoxamide tromethamine salt [mi]
lodoxamide tromethamine salt
lodoxamide trometamol [mart.]
S10929
lodoxamidetromethamine
HY-16289
CS-6465
lodoxamide (tromethamine)
CHEMBL3989725
DS-4322
mfcd04112765
2-amino-2-(hydroxymethyl)propane-1,3-diol hemi(2,2'-((2-chloro-5-cyano-1,3-phenylene)bis(azanediyl))bis(2-oxoacetate))
lodoxamide tromethamide
Q27260799
2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid
S5674
2,2'-((2-chloro-5-cyano-1,3-phenylene)diimino)bis(2-oxoacetic acid), compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)
lodoxamide trometamol (mart.)

Research Excerpts

Overview

Lodoxamide tromethamine (U-42,585E) is a new drug intended for prophylaxis of mast cell-mediated allergic disease.

ExcerptReferenceRelevance
"Lodoxamide tromethamine (U-42,585E) is a new drug intended for prophylaxis of mast cell-mediated allergic disease. "( Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Bewtra, AK; Bui, TC; Townley, RG; Watt, GD, 1980
)
2.02

Dosage Studied

ExcerptRelevanceReference
" Analysis of allergen dose-response curve parameters shows that pretreatment with lodoxamide offers significant protection against experimental allergen-induced bronchoconstriction."( Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Bewtra, AK; Bui, TC; Townley, RG; Watt, GD, 1980
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (71.43)18.7374
1990's9 (25.71)18.2507
2000's1 (2.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.28 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (24.32%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (5.41%)4.05%
Observational0 (0.00%)0.25%
Other26 (70.27%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]